These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10351680)

  • 1. Economic analysis of outreach assessment clinics in breast screening programmes.
    van der Pol MM; Cairns JA; Gilbert FJ; Hendry PJ
    Int J Health Plann Manage; 1999; 14(1):57-67. PubMed ID: 10351680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The costs of mammography screening in New Zealand: evidence from the pilot programmes.
    Menon A; Devlin NJ; Richardson AK
    N Z Med J; 1994 Dec; 107(991):501-3. PubMed ID: 7830979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions?
    Wang PE; Wang TT; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S54-8. PubMed ID: 17227644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services.
    Lynch FL; Whitlock EP; Valanis BG; Smith SK
    Prev Med; 2004 Apr; 38(4):403-11. PubMed ID: 15020173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Economic approach to breast cancer screening in Belgium].
    Autier P; Grivegnée AR
    Rev Med Brux; 1995; 16(4):326-9. PubMed ID: 7481252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
    Taneja C; Edelsberg J; Weycker D; Guo A; Oster G; Weinreb J
    J Am Coll Radiol; 2009 Mar; 6(3):171-9. PubMed ID: 19248993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety net: a cost-effective approach to improving breast and cervical cancer screening.
    Vogt TM; Glass A; Glasgow RE; La Chance PA; Lichtenstein E
    J Womens Health (Larchmt); 2003 Oct; 12(8):789-98. PubMed ID: 14588129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An academic health center cost analysis of screening mammography: creating a financially viable service.
    Chen SL; Clark S; Pierce LJ; Hayes DF; Helvie MA; Greeno PL; Newman LA; Chang AE
    Cancer; 2004 Sep; 101(5):1043-50. PubMed ID: 15329914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to cervical and breast cancer programs is crucial to improving screening performance.
    Mauad EC; Nicolau SM; Moreira LF; Haikel RL; Longatto-Filho A; Baracat EC
    Rural Remote Health; 2009; 9(3):1241. PubMed ID: 19778158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres.
    Törnberg S; Codd M; Rodrigues V; Segnan N; Ponti A
    J Med Screen; 2005; 12(1):43-9. PubMed ID: 15814019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a breast cancer screening programme in Shiraz, Islamic Republic of Iran.
    Hadi N; Sadeghi-Hassanabadi A; Talei AR; Arasteh MM; Kazerooni T
    East Mediterr Health J; 2002; 8(2-3):386-92. PubMed ID: 15339128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district].
    Giorgi R; Reynaud J; Wait S; Seradour B
    Bull Cancer; 2005 Nov; 92(11):995-1001. PubMed ID: 16316834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Economic approach to breast cancer screening in Belgium].
    Grivegnée AR; Autier P
    Rev Med Brux; 2001 Sep; 22(4):A277-81. PubMed ID: 11680188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of health care, cost, and culture on breast cancer screening: issues facing urban American Indian women.
    Risendal B; Roe D; DeZapien J; Papenfuss M; Giuliano A
    Prev Med; 1999 Dec; 29(6 Pt 1):501-9. PubMed ID: 10600431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
    Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for breast cancer in England: past and future.
    Advisory Committee on Breast Cancer Screening
    J Med Screen; 2006; 13(2):59-61. PubMed ID: 16792825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cost of breast cancer screening in France].
    Wait S; Schaffer P; Séradour B; Guldenfels C; Gairard B; Morin F; Piana L
    J Radiol; 2000 Jul; 81(7):799-806. PubMed ID: 10915994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.